As per the report published by Allied Market Research, the global Erythropoietin Drugs Market was pegged at $9.24 billion in 2020, and is estimated to reach $14.41 billion by 2028, growing at a CAGR of 5.7% from 2021 to 2028. The study analyzes the important strategies, drivers, competition, market dynamics, size, a.
The Senate HELP Committee begin consideration of four bills related to pharmacy benefit manager PBM reforms and expanding the availability of low-cost generic drugs. White House Announces End of COVID-19 Vaccination Requirements. DEA on Telehealth Flexibilities
Rise in chronic diseases such as cancer and diabetes, high-end technological advancements in the healthcare sector, and surge in awareness regarding controlled drug delivery drive the growth